I try to be as transparent as possible about my conflicts of interests. If these conflicts cause an issue with the work or working relationship between me and a lab member, I want people to have those conversations with me early. My department chair would be a good person to talk to if you don’t feel comfortable talking to me about it directly.

Appointments:

• Professor, Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy and Medicine , University of California San Francisco
• Vice Dean - Research, School of Pharmacy, University of California San Francisco
• Faculty Scientist,Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory
• Associate Director and Member, Quantitative Biosciences Institute, University of California San Francisco
• Associate Director, Biophysics Graduate Program, University of California San Francisco
• Board Member and Vice President, ASAPbio

Equity (held in Trust, with spouse):

• Relay Therapeutics
• Impossible Foods
• Arda Therapeutics
• Profluent Bio
• Interdict Bio (co-founder)

Consulting/speaker fees/travel within last 2 years:

• Relay Therapeutics
• Olema Oncology
• Merck
• Octant
• RADD Pharmaceuticals
• RA Capital
• Profluent Bio
• Past: MoMa Therapeutics, Novartis, Arcadia Science, Genentech, Revolution Medicines, Third Rock Ventures, Calico, GSK, Schrodinger, CCG, OpenEye, Roche, AstraZeneca, Global Blood Therapeutics

Sponsored and Collaborative Research:

• Relay Therapeutics
• Salesforce

I also am the head of the participating research team of beamline 8.3.1. at the Advanced Light Source. Many companies use that beamline or sponsor research and development activities by the beamline scientists, including: Plexxikon, Relay Therapeutics, Eli Lilly and Company, and Global Blood Therapeutics.